Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis
Gespeichert in:
| Veröffentlicht in: | Journal of dermatology 2020-04, Vol.47 (4), p.e110-e111 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e111 |
|---|---|
| container_issue | 4 |
| container_start_page | e110 |
| container_title | Journal of dermatology |
| container_volume | 47 |
| creator | Ito, Michiko Hirota, Tomomitsu Momose, Mami Ito, Toshihiro Umezawa, Yoshinori Fukuchi, Osamu Asahina, Akihiko Nakagawa, Hidemi Tamari, Mayumi Saeki, Hidehisa |
| description | |
| doi_str_mv | 10.1111/1346-8138.15200 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2330338269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2385075144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3950-da9b97dc54c7044477d6d1ebf08c95fb70d640248fcef9e110b1131c9297b0723</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi1ERbeFMzdkiQsH0o5jO06ObemWVitAUM6W4zisSxIbO1G1tz4CT8DD9UlwutseuOCDrRl9_z9j_Qi9JnBE0jkmlBVZSWh5RHgO8AwtnjrP0QJoybOcgdhHBzHeAOQVJ_AC7VNSipzxYoH-rJT-iV2LVYxOWzVaN8zl9aflyfv5_vptSU6xGpqH1uUXin-YwWDvuk3vgl_b2Ed8a8c1DiZ6N0SDR5f40d7f_R6nxODB6OCijbhVekz1uDZB-Q22A75SXg0maXyabIZxZ-WjC1YlyUu016oumle79xB9X55fn33MVp8vLs9OVpmmFYesUVVdiUZzpgUwxoRoioaYuoVSV7ytBTQFg5yVrTZtZQiBmhBKdJVXogaR00P0buvrg_s1mTjK3kZtui5t56Yoc0qB0jIvqoS-_Qe9cVMY0naJKjkIThhL1PGWmr8eg2mlD7ZXYSMJyDk6OQcl56DkQ3RJ8WbnO9W9aZ74x6wSwLfAre3M5n9-8urD-db4LzERo9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2385075144</pqid></control><display><type>article</type><title>Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ito, Michiko ; Hirota, Tomomitsu ; Momose, Mami ; Ito, Toshihiro ; Umezawa, Yoshinori ; Fukuchi, Osamu ; Asahina, Akihiko ; Nakagawa, Hidemi ; Tamari, Mayumi ; Saeki, Hidehisa</creator><creatorcontrib>Ito, Michiko ; Hirota, Tomomitsu ; Momose, Mami ; Ito, Toshihiro ; Umezawa, Yoshinori ; Fukuchi, Osamu ; Asahina, Akihiko ; Nakagawa, Hidemi ; Tamari, Mayumi ; Saeki, Hidehisa</creatorcontrib><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.15200</identifier><identifier>PMID: 31872456</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adalimumab - pharmacology ; Adalimumab - therapeutic use ; Adult ; Aged ; Asian Continental Ancestry Group - genetics ; Dermatologic Agents - pharmacology ; Dermatologic Agents - therapeutic use ; Drug Resistance - genetics ; Female ; Genotyping Techniques ; Humans ; Infliximab - pharmacology ; Infliximab - therapeutic use ; Japan ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Psoriasis ; Psoriasis - drug therapy ; Psoriasis - genetics ; Receptors, Tumor Necrosis Factor, Type II - genetics ; Tumor Necrosis Factor alpha-Induced Protein 3 - genetics ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; Tumor Necrosis Factor-alpha - genetics</subject><ispartof>Journal of dermatology, 2020-04, Vol.47 (4), p.e110-e111</ispartof><rights>2019 Japanese Dermatological Association</rights><rights>Copyright © 2020 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3950-da9b97dc54c7044477d6d1ebf08c95fb70d640248fcef9e110b1131c9297b0723</citedby><cites>FETCH-LOGICAL-c3950-da9b97dc54c7044477d6d1ebf08c95fb70d640248fcef9e110b1131c9297b0723</cites><orcidid>0000-0001-8884-1223 ; 0000-0001-6127-3182 ; 0000-0002-9517-4374 ; 0000-0002-8568-8187 ; 0000-0002-1095-0355</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.15200$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.15200$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31872456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ito, Michiko</creatorcontrib><creatorcontrib>Hirota, Tomomitsu</creatorcontrib><creatorcontrib>Momose, Mami</creatorcontrib><creatorcontrib>Ito, Toshihiro</creatorcontrib><creatorcontrib>Umezawa, Yoshinori</creatorcontrib><creatorcontrib>Fukuchi, Osamu</creatorcontrib><creatorcontrib>Asahina, Akihiko</creatorcontrib><creatorcontrib>Nakagawa, Hidemi</creatorcontrib><creatorcontrib>Tamari, Mayumi</creatorcontrib><creatorcontrib>Saeki, Hidehisa</creatorcontrib><title>Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><subject>Adalimumab - pharmacology</subject><subject>Adalimumab - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Asian Continental Ancestry Group - genetics</subject><subject>Dermatologic Agents - pharmacology</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Drug Resistance - genetics</subject><subject>Female</subject><subject>Genotyping Techniques</subject><subject>Humans</subject><subject>Infliximab - pharmacology</subject><subject>Infliximab - therapeutic use</subject><subject>Japan</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Psoriasis</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - genetics</subject><subject>Receptors, Tumor Necrosis Factor, Type II - genetics</subject><subject>Tumor Necrosis Factor alpha-Induced Protein 3 - genetics</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi1ERbeFMzdkiQsH0o5jO06ObemWVitAUM6W4zisSxIbO1G1tz4CT8DD9UlwutseuOCDrRl9_z9j_Qi9JnBE0jkmlBVZSWh5RHgO8AwtnjrP0QJoybOcgdhHBzHeAOQVJ_AC7VNSipzxYoH-rJT-iV2LVYxOWzVaN8zl9aflyfv5_vptSU6xGpqH1uUXin-YwWDvuk3vgl_b2Ed8a8c1DiZ6N0SDR5f40d7f_R6nxODB6OCijbhVekz1uDZB-Q22A75SXg0maXyabIZxZ-WjC1YlyUu016oumle79xB9X55fn33MVp8vLs9OVpmmFYesUVVdiUZzpgUwxoRoioaYuoVSV7ytBTQFg5yVrTZtZQiBmhBKdJVXogaR00P0buvrg_s1mTjK3kZtui5t56Yoc0qB0jIvqoS-_Qe9cVMY0naJKjkIThhL1PGWmr8eg2mlD7ZXYSMJyDk6OQcl56DkQ3RJ8WbnO9W9aZ74x6wSwLfAre3M5n9-8urD-db4LzERo9A</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Ito, Michiko</creator><creator>Hirota, Tomomitsu</creator><creator>Momose, Mami</creator><creator>Ito, Toshihiro</creator><creator>Umezawa, Yoshinori</creator><creator>Fukuchi, Osamu</creator><creator>Asahina, Akihiko</creator><creator>Nakagawa, Hidemi</creator><creator>Tamari, Mayumi</creator><creator>Saeki, Hidehisa</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8884-1223</orcidid><orcidid>https://orcid.org/0000-0001-6127-3182</orcidid><orcidid>https://orcid.org/0000-0002-9517-4374</orcidid><orcidid>https://orcid.org/0000-0002-8568-8187</orcidid><orcidid>https://orcid.org/0000-0002-1095-0355</orcidid></search><sort><creationdate>202004</creationdate><title>Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis</title><author>Ito, Michiko ; Hirota, Tomomitsu ; Momose, Mami ; Ito, Toshihiro ; Umezawa, Yoshinori ; Fukuchi, Osamu ; Asahina, Akihiko ; Nakagawa, Hidemi ; Tamari, Mayumi ; Saeki, Hidehisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3950-da9b97dc54c7044477d6d1ebf08c95fb70d640248fcef9e110b1131c9297b0723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adalimumab - pharmacology</topic><topic>Adalimumab - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Asian Continental Ancestry Group - genetics</topic><topic>Dermatologic Agents - pharmacology</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Drug Resistance - genetics</topic><topic>Female</topic><topic>Genotyping Techniques</topic><topic>Humans</topic><topic>Infliximab - pharmacology</topic><topic>Infliximab - therapeutic use</topic><topic>Japan</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Psoriasis</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - genetics</topic><topic>Receptors, Tumor Necrosis Factor, Type II - genetics</topic><topic>Tumor Necrosis Factor alpha-Induced Protein 3 - genetics</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Michiko</creatorcontrib><creatorcontrib>Hirota, Tomomitsu</creatorcontrib><creatorcontrib>Momose, Mami</creatorcontrib><creatorcontrib>Ito, Toshihiro</creatorcontrib><creatorcontrib>Umezawa, Yoshinori</creatorcontrib><creatorcontrib>Fukuchi, Osamu</creatorcontrib><creatorcontrib>Asahina, Akihiko</creatorcontrib><creatorcontrib>Nakagawa, Hidemi</creatorcontrib><creatorcontrib>Tamari, Mayumi</creatorcontrib><creatorcontrib>Saeki, Hidehisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Michiko</au><au>Hirota, Tomomitsu</au><au>Momose, Mami</au><au>Ito, Toshihiro</au><au>Umezawa, Yoshinori</au><au>Fukuchi, Osamu</au><au>Asahina, Akihiko</au><au>Nakagawa, Hidemi</au><au>Tamari, Mayumi</au><au>Saeki, Hidehisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2020-04</date><risdate>2020</risdate><volume>47</volume><issue>4</issue><spage>e110</spage><epage>e111</epage><pages>e110-e111</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31872456</pmid><doi>10.1111/1346-8138.15200</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-8884-1223</orcidid><orcidid>https://orcid.org/0000-0001-6127-3182</orcidid><orcidid>https://orcid.org/0000-0002-9517-4374</orcidid><orcidid>https://orcid.org/0000-0002-8568-8187</orcidid><orcidid>https://orcid.org/0000-0002-1095-0355</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0385-2407 |
| ispartof | Journal of dermatology, 2020-04, Vol.47 (4), p.e110-e111 |
| issn | 0385-2407 1346-8138 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2330338269 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adalimumab - pharmacology Adalimumab - therapeutic use Adult Aged Asian Continental Ancestry Group - genetics Dermatologic Agents - pharmacology Dermatologic Agents - therapeutic use Drug Resistance - genetics Female Genotyping Techniques Humans Infliximab - pharmacology Infliximab - therapeutic use Japan Male Middle Aged Polymorphism, Single Nucleotide Psoriasis Psoriasis - drug therapy Psoriasis - genetics Receptors, Tumor Necrosis Factor, Type II - genetics Tumor Necrosis Factor alpha-Induced Protein 3 - genetics Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - genetics |
| title | Lack of association of TNFA, TNFRSF1B and TNFAIP3 gene polymorphisms with response to anti‐tumor necrosis factor therapy in Japanese patients with psoriasis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T04%3A50%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20association%20of%20TNFA,%20TNFRSF1B%20and%20TNFAIP3%20gene%20polymorphisms%20with%20response%20to%20anti%E2%80%90tumor%20necrosis%20factor%20therapy%20in%20Japanese%20patients%20with%20psoriasis&rft.jtitle=Journal%20of%20dermatology&rft.au=Ito,%20Michiko&rft.date=2020-04&rft.volume=47&rft.issue=4&rft.spage=e110&rft.epage=e111&rft.pages=e110-e111&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.15200&rft_dat=%3Cproquest_cross%3E2385075144%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2385075144&rft_id=info:pmid/31872456&rfr_iscdi=true |